Sagimet Biosciences Inc.
SGMT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $2 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $2 | $0 | $0 |
| % Margin | – | 100% | – | – |
| R&D Expenses | $38 | $20 | $25 | $19 |
| G&A Expenses | $16 | $13 | $6 | $4 |
| SG&A Expenses | $16 | $13 | $6 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $54 | $33 | $31 | $24 |
| Operating Income | -$54 | -$31 | -$31 | -$24 |
| % Margin | – | -1,537% | – | – |
| Other Income/Exp. Net | $9 | $3 | $1 | -$1 |
| Pre-Tax Income | -$46 | -$28 | -$30 | -$24 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$46 | -$28 | -$30 | -$24 |
| % Margin | – | -1,393.8% | – | – |
| EPS | -1.45 | -1.53 | -1.38 | -1.1 |
| % Growth | 5.2% | -10.9% | -25.5% | – |
| EPS Diluted | -1.45 | -1.53 | -1.38 | -1.1 |
| Weighted Avg Shares Out | 31 | 18 | 22 | 22 |
| Weighted Avg Shares Out Dil | 31 | 18 | 22 | 22 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$46 | -$31 | -$31 | -$24 |
| % Margin | – | -1,537% | – | – |